PL355109A1 - Tert. - Google Patents

Tert.

Info

Publication number: PL355109A1
Authority: PL; Poland
Prior art keywords: tert
Prior art date: 1999-10-08

Application number

PL00355109A

Other languages

English (en)

Polish (pl)

Inventor

Corinna Maul

Bernd Sundermann

Hagen-Heinrich Hennies

Johannes Schneider

Matthias Gerlach

Original Assignee

Grunenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-08

Filing date

2000-10-06

Publication date

2004-04-05

2000-10-06 Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh

2004-04-05 Publication of PL355109A1 publication Critical patent/PL355109A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Psychology (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL00355109A 1999-10-08 2000-10-06 Tert. PL355109A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19948434A DE19948434A1 (de)	1999-10-08	1999-10-08	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
PCT/EP2000/009791 WO2001027109A2 (de)	1999-10-08	2000-10-06	Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridin-3-yl)-amin-derivate

Publications (1)

Publication Number	Publication Date
PL355109A1 true PL355109A1 (en)	2004-04-05

Family

ID=7924888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL00355109A PL355109A1 (en)	1999-10-08	2000-10-06	Tert.

Country Status (28)

Country	Link
US (1)	US6703404B2 (de)
EP (1)	EP1218378B1 (de)
JP (1)	JP2003511450A (de)
KR (1)	KR100793619B1 (de)
CN (1)	CN1208336C (de)
AR (2)	AR025959A1 (de)
AT (1)	ATE238304T1 (de)
AU (2)	AU7419900A (de)
BR (1)	BR0014827A (de)
CA (1)	CA2386804A1 (de)
CO (2)	CO5210861A1 (de)
CZ (1)	CZ20021241A3 (de)
DE (2)	DE19948434A1 (de)
DK (1)	DK1218378T3 (de)
ES (1)	ES2198355T3 (de)
HK (1)	HK1047749B (de)
HU (1)	HUP0203545A3 (de)
IL (3)	IL148997A0 (de)
MX (1)	MXPA02003546A (de)
NO (1)	NO20021564L (de)
NZ (1)	NZ518438A (de)
PE (2)	PE20010706A1 (de)
PL (1)	PL355109A1 (de)
PT (1)	PT1218378E (de)
RU (1)	RU2002110281A (de)
SK (1)	SK4622002A3 (de)
WO (2)	WO2001027119A2 (de)
ZA (2)	ZA200203579B (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083966A (en)	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
EP1143951A3 (de)	1998-09-21	2002-02-06	University Of Florida Research Foundation, Inc.	Mittel gegen malaria
AU2001251444A1 (en)	2000-04-10	2001-10-23	Merck And Co., Inc.	Inhibitors of prenyl-protein transferase
DE10043845A1 (de) *	2000-09-06	2002-03-14	Gruenenthal Gmbh	Verfahren zur Messung der Aktivität der NO-Synthase
DE10050663A1 (de) *	2000-10-13	2002-04-18	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
WO2002048146A2 (de) *	2000-12-13	2002-06-20	Basf Aktiengesellschaft	Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
DE10117184A1 (de) *	2001-04-05	2002-10-17	Gruenenthal Gmbh	Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10117183A1 (de) *	2001-04-05	2002-10-10	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
DE10132726A1 (de) *	2001-07-05	2003-02-27	Gruenenthal Gmbh	Verwendung von substituierten gamma-Lactonverbindungen als Arzneimittel
AU2003223049A1 (en)	2002-03-13	2003-09-22	Euro-Celtique S.A.	Aryl substituted pyrimidines and the use thereof
EP1509526A2 (de)	2002-04-19	2005-03-02	Cellular Genomics Inc.	Imidazo(1,2-a)pyrazin-8-ylamine, verfahren zu ihrer herstellung und methoden zu ihrer verwendung
US20050197435A1 (en) *	2002-06-14	2005-09-08	Dotson Darin L.	Polymer additive compositions for bimolecular nucleation in thermoplastics
WO2004022562A1 (en)	2002-09-09	2004-03-18	Cellular Genomics, Inc.	6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
DE10246890A1 (de)	2002-10-08	2004-04-22	Grünenthal GmbH	Substituierte C-Imidazo[1,2-alpyridin-3-yl-methylamine
WO2004058755A2 (en) *	2002-12-24	2004-07-15	Biofocus Plc	Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
WO2004072080A1 (en)	2003-02-10	2004-08-26	Cellular Genomics, Inc.	Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity
WO2005014599A1 (en)	2003-06-04	2005-02-17	Cellular Genomics, Inc.	Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
US7393848B2 (en)	2003-06-30	2008-07-01	Cgi Pharmaceuticals, Inc.	Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
WO2005019220A2 (en)	2003-08-11	2005-03-03	Cellular Genomics Inc.	Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
WO2005034949A1 (en)	2003-09-09	2005-04-21	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
DE102004021716A1 (de) *	2004-04-30	2005-12-01	Grünenthal GmbH	Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
DE102004044884A1 (de)	2004-09-14	2006-05-24	Grünenthal GmbH	Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
EP1805142A4 (de)	2004-09-23	2009-06-10	Reddy Us Therapeutics Inc	Neue pyridinverbindungen, verfahren zu ihrer herstellung und zusammensetzungen damit
WO2006107626A1 (en)	2005-04-04	2006-10-12	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues
DE102005016547A1 (de) *	2005-04-08	2006-10-12	Grünenthal GmbH	Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
US7777040B2 (en)	2005-05-03	2010-08-17	Cgi Pharmaceuticals, Inc.	Certain substituted ureas, as modulators of kinase activity
RU2007147382A (ru)	2005-05-20	2009-06-27	Эррэй Биофарма Инк. (Us)	Соединения, являющиеся ингибиторами raf, и способы их применения
US7855289B2 (en)	2005-08-04	2010-12-21	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US8088928B2 (en)	2005-08-04	2012-01-03	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US8093401B2 (en)	2005-08-04	2012-01-10	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US20070037865A1 (en)	2005-08-04	2007-02-15	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
WO2007028051A2 (en)	2005-09-02	2007-03-08	Abbott Laboratories	Novel imidazo based heterocycles
HUE047422T2 (hu)	2005-12-23	2020-04-28	Ariad Pharma Inc	Biciklusos heteroaril vegyületek
DE102006011574A1 (de)	2006-03-10	2007-10-31	Grünenthal GmbH	Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
PL2001892T3 (pl)	2006-03-17	2013-09-30	Ambit Biosciences Corp	Imidazolotiazolowe związki do leczenia chorób proliferacyjnych
CA2680592C (en)	2007-03-15	2016-07-05	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues and uses thereof in treating pathological conditions
WO2008134553A1 (en) *	2007-04-26	2008-11-06	Xenon Pharmaceuticals Inc.	Methods of using bicyclic compounds in treating sodium channel-mediated diseases
GB0708188D0 (en) *	2007-04-27	2007-06-06	Merck Sharp & Dohme	Therapeutic compounds
TW200918542A (en)	2007-06-20	2009-05-01	Sirtris Pharmaceuticals Inc	Sirtuin modulating compounds
CL2008001822A1 (es)	2007-06-20	2009-03-13	Sirtris Pharmaceuticals Inc	Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
DE102007040336A1 (de) *	2007-08-27	2009-03-05	Johann Wolfgang Goethe-Universität Frankfurt am Main	Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen
DK2201018T3 (en)	2007-09-19	2016-05-17	Ambit Biosciences Corp	SOLID FORMS COMPRISING N- (5-TERT-BUTYL-ISOXAZOL-3-YL) -N '- {4- [7- (2-morpholin-4-yl-ethoxy) imidazo [2,1-b] [1, 3] benzothiazole-2-YL] PHENYL} UREA, COMPOSITIONS THEREOF AND USES THEREFORE
US20090221612A1 (en)	2008-02-13	2009-09-03	Mitchell Scott A	Certain substituted amides, method of making, and method of use thereof
NZ588376A (en) *	2008-04-15	2011-06-30	Eisai R&D Man Co Ltd	3-phenylpyrazolo[5,1-b]thiazole compound having antagonism against corticotropin-releasing factor (CRF) receptor
CN102216298B (zh)	2008-09-16	2014-04-16	Csir公司	作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶
WO2010068258A1 (en)	2008-12-08	2010-06-17	Cgi Pharmaceuticals, Inc.	Imidazopyrazine syk inhibitors
US8450321B2 (en)	2008-12-08	2013-05-28	Gilead Connecticut, Inc.	6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
LT2716157T (lt)	2008-12-08	2016-09-12	Gilead Connecticut, Inc.	Imidazopirazino syk inhibitoriai
MX2011006555A (es)	2008-12-19	2011-08-03	Sirtris Pharmaceuticals Inc	Compuestos de tiazolopiridina moduladores de sirtuina.
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
MX350010B (es)	2010-03-11	2017-08-23	Gilead Connecticut Inc	Inhibidores syk de imidazopiridinas.
US20140343110A1 (en)	2011-12-16	2014-11-20	University Of Florida Research Foundation, Inc.	Uses of 4'-desferrithiocin analogs
JP6101343B2 (ja)	2012-04-26	2017-03-22	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	血小板凝集を治療するためのプロテアーゼ活性化受容体４（ｐａｒ４）阻害剤としてのイミダゾチアジアゾールおよびイミダゾピリダジン誘導体
JP6181744B2 (ja)	2012-04-26	2017-08-16	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	血小板凝集を治療するためのプロテアーゼ活性化受容体４（ｐａｒ４）阻害剤としてのイミダゾチアジアゾール誘導体
HUE060743T2 (hu)	2012-04-26	2023-04-28	Bristol Myers Squibb Co	Gyógyszerészeti kompozíciók, amelyek tartalmaznak imidazothiadiazol- és imidazopiridazinszármazékokat mint proteáz aktívált receptor 4 (PAR4) inhibitorokat trombocitaaggregációk kezelésére
JP2016504988A (ja) *	2012-11-14	2016-02-18	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	イミダゾピリジン誘導体
NZ715776A (en)	2013-07-30	2017-04-28	Gilead Connecticut Inc	Polymorph of syk inhibitors
JP6153667B2 (ja)	2013-07-30	2017-06-28	ギリアードコネチカット，インコーポレイテッド	Ｓｋｙ阻害剤の製剤
WO2015077655A1 (en)	2013-11-22	2015-05-28	University Of Florida Research Foundation, Inc.	Desferrithiocin analogs and uses thereof
EP3076976B1 (de)	2013-12-04	2020-09-02	Gilead Sciences, Inc.	Methode zur behandlung von krebs
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
TWI735853B (zh)	2013-12-23	2021-08-11	美商克洛諾斯生技有限公司	脾酪胺酸激酶抑制劑
WO2015123437A1 (en)	2014-02-13	2015-08-20	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
TWI720451B (zh)	2014-02-13	2021-03-01	美商英塞特控股公司	作為lsd1抑制劑之環丙胺
WO2015123408A1 (en)	2014-02-13	2015-08-20	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
US9670210B2 (en)	2014-02-13	2017-06-06	Incyte Corporation	Cyclopropylamines as LSD1 inhibitors
US9598419B1 (en)	2014-06-24	2017-03-21	Universite De Montreal	Imidazotriazine and imidazodiazine compounds
US9617279B1 (en)	2014-06-24	2017-04-11	Bristol-Myers Squibb Company	Imidazooxadiazole compounds
WO2016007727A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007736A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TWI687419B (zh)	2014-07-10	2020-03-11	美商英塞特公司	作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
MX2017000610A (es)	2014-07-14	2017-04-27	Gilead Sciences Inc	Metodos combinados para tratar canceres.
MX373154B (es)	2015-04-03	2020-04-22	Incyte Holdings Corp	Compuestos heterocíclicos como inhibidores de demetilasa 1 específica de lisina (lsd1).
CA2984250A1 (en)	2015-04-27	2016-11-03	University Of Florida Research Foundation, Incorporated	Metabolically programmed metal chelators and uses thereof
LT3334709T (lt)	2015-08-12	2025-03-10	Incyte Holdings Corporation	Lsd1 inhibitoriaus druskos
UA125559C2 (uk)	2016-04-22	2022-04-20	Інсайт Корпорейшн	Композиції інгібітора lsd1
WO2019014514A1 (en) *	2017-07-14	2019-01-17	University Of Massachusetts	HETEROCYCLIC COMPOUNDS AND USES THEREOF
US11384082B2 (en)	2017-08-25	2022-07-12	Kronos Bio, Inc.	Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors
AU2018346331B2 (en) *	2017-10-04	2023-08-24	Dana-Farber Cancer Institute, Inc.	Small molecule inhibition of transcription factor SALL4 and uses thereof
US10968200B2 (en)	2018-08-31	2021-04-06	Incyte Corporation	Salts of an LSD1 inhibitor and processes for preparing the same
CN113950479A (zh)	2019-02-22	2022-01-18	克洛诺斯生物股份有限公司	作为syk抑制剂的缩合吡嗪的固体形式
WO2024220541A1 (en) *	2023-04-18	2024-10-24	Kallyope, Inc.	Nk3 modulators and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3489755A (en) *	1966-08-03	1970-01-13	Pfizer & Co C	Imidazo (1,2-b) pyridazines
FR2463774A1 (fr) *	1979-08-21	1981-02-27	Yamanouchi Pharma Co Ltd	Derives du 2-phenylimidazo(2,1-b)benzothiazole
DE3269604D1 (en) *	1981-06-26	1986-04-10	Schering Corp	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
NZ221996A (en) *	1986-10-07	1989-08-29	Yamanouchi Pharma Co Ltd	Imidazo-pyridine derivatives and pharmaceutical compositions
FR2638161B1 (fr) *	1988-10-24	1991-01-11	Centre Nat Rech Scient	Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
JPH08333258A (ja) *	1994-12-14	1996-12-17	Japan Tobacco Inc	チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
GB9506188D0 (en) *	1995-03-27	1995-05-17	Fujisawa Pharmaceutical Co	Amidine derivatives
US5908842A (en) *	1995-12-08	1999-06-01	Merck & Co., Inc.	Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
WO1998006724A1 (en) *	1996-08-09	1998-02-19	Yamanouchi Pharmaceutical Co., Ltd.	Metabotropic glutamate receptor agonists
AUPP278498A0 (en) *	1998-04-03	1998-04-30	Australian Nuclear Science & Technology Organisation	Peripheral benzodiazepine receptor binding agents

1999
- 1999-10-08 DE DE19948434A patent/DE19948434A1/de not_active Withdrawn
2000
- 2000-09-18 AU AU74199/00A patent/AU7419900A/en not_active Abandoned
- 2000-09-18 IL IL14899700A patent/IL148997A0/xx not_active IP Right Cessation
- 2000-09-18 WO PCT/EP2000/009098 patent/WO2001027119A2/de not_active Ceased
- 2000-10-02 CO CO00074640A patent/CO5210861A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105250A patent/AR025959A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105251A patent/AR025960A1/es not_active Application Discontinuation
- 2000-10-06 AU AU79153/00A patent/AU780526B2/en not_active Ceased
- 2000-10-06 SK SK462-2002A patent/SK4622002A3/sk unknown
- 2000-10-06 JP JP2001530327A patent/JP2003511450A/ja active Pending
- 2000-10-06 ES ES00969439T patent/ES2198355T3/es not_active Expired - Lifetime
- 2000-10-06 DK DK00969439T patent/DK1218378T3/da active
- 2000-10-06 HU HU0203545A patent/HUP0203545A3/hu unknown
- 2000-10-06 CN CNB008167079A patent/CN1208336C/zh not_active Expired - Fee Related
- 2000-10-06 KR KR1020027004518A patent/KR100793619B1/ko not_active Expired - Fee Related
- 2000-10-06 CA CA002386804A patent/CA2386804A1/en not_active Abandoned
- 2000-10-06 CO CO00076179A patent/CO5251429A1/es not_active Application Discontinuation
- 2000-10-06 PT PT00969439T patent/PT1218378E/pt unknown
- 2000-10-06 NZ NZ518438A patent/NZ518438A/en not_active IP Right Cessation
- 2000-10-06 MX MXPA02003546A patent/MXPA02003546A/es active IP Right Grant
- 2000-10-06 PE PE2000001062A patent/PE20010706A1/es not_active Application Discontinuation
- 2000-10-06 HK HK02109385.2A patent/HK1047749B/zh not_active IP Right Cessation
- 2000-10-06 IL IL14899900A patent/IL148999A0/xx active IP Right Grant
- 2000-10-06 BR BR0014827-0A patent/BR0014827A/pt not_active IP Right Cessation
- 2000-10-06 PL PL00355109A patent/PL355109A1/xx not_active IP Right Cessation
- 2000-10-06 EP EP00969439A patent/EP1218378B1/de not_active Expired - Lifetime
- 2000-10-06 AT AT00969439T patent/ATE238304T1/de active
- 2000-10-06 WO PCT/EP2000/009791 patent/WO2001027109A2/de not_active Ceased
- 2000-10-06 DE DE50001911T patent/DE50001911D1/de not_active Expired - Lifetime
- 2000-10-06 RU RU2002110281/04A patent/RU2002110281A/ru not_active Application Discontinuation
- 2000-10-06 CZ CZ20021241A patent/CZ20021241A3/cs unknown
- 2000-10-06 PE PE2000001063A patent/PE20010632A1/es not_active Application Discontinuation
2002
- 2002-04-03 NO NO20021564A patent/NO20021564L/no not_active Application Discontinuation
- 2002-04-04 IL IL148999A patent/IL148999A/en not_active IP Right Cessation
- 2002-04-08 US US10/117,339 patent/US6703404B2/en not_active Expired - Fee Related
- 2002-05-06 ZA ZA200203579A patent/ZA200203579B/xx unknown
- 2002-05-06 ZA ZA200203581A patent/ZA200203581B/xx unknown

Also Published As

Publication number	Publication date
HK1047749B (zh)	2003-08-22
NO20021564L (no)	2002-06-04
PE20010632A1 (es)	2001-07-07
ZA200203581B (en)	2004-02-25
KR100793619B1 (ko)	2008-01-11
IL148999A (en)	2007-03-08
AR025960A1 (es)	2002-12-26
CN1407983A (zh)	2003-04-02
DE19948434A1 (de)	2001-06-07
US20030022914A1 (en)	2003-01-30
ZA200203579B (en)	2003-10-29
AU7915300A (en)	2001-04-23
ES2198355T3 (es)	2004-02-01
WO2001027119A3 (de)	2001-10-11
NZ518438A (en)	2004-08-27
EP1218378A2 (de)	2002-07-03
WO2001027119A2 (de)	2001-04-19
BR0014827A (pt)	2003-07-08
KR20020069003A (ko)	2002-08-28
CO5210861A1 (es)	2002-10-30
CN1208336C (zh)	2005-06-29
NO20021564D0 (no)	2002-04-03
IL148999A0 (en)	2002-11-10
ATE238304T1 (de)	2003-05-15
EP1218378B1 (de)	2003-04-23
AU7419900A (en)	2001-04-23
US6703404B2 (en)	2004-03-09
HK1047749A1 (en)	2003-03-07
PT1218378E (pt)	2003-09-30
HUP0203545A2 (hu)	2003-02-28
WO2001027109A2 (de)	2001-04-19
CO5251429A1 (es)	2003-02-28
PE20010706A1 (es)	2001-08-13
AU780526B2 (en)	2005-03-24
WO2001027109A3 (de)	2001-09-20
RU2002110281A (ru)	2003-12-20
IL148997A0 (en)	2002-11-10
SK4622002A3 (en)	2002-09-10
HUP0203545A3 (en)	2004-07-28
CA2386804A1 (en)	2001-04-19
MXPA02003546A (es)	2002-09-18
AR025959A1 (es)	2002-12-26
CZ20021241A3 (cs)	2002-08-14
DK1218378T3 (da)	2003-07-21
DE50001911D1 (de)	2003-05-28
JP2003511450A (ja)	2003-03-25

Publication	Publication Date	Title
PL355109A1 (en)	2004-04-05	Tert.
MXPA01013362A (es)	2003-09-04	Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200200477B (en)	2003-06-25	2-pyrazolin-5-ones.
EG24361A (en)	2009-03-04	4-pyrimiding1-n-acy1.l.phenlalanines
ZA996185B (en)	2000-04-10	Sulfanylsilanes.
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA200103880B (en)	2001-11-22	Catalyst.
ZA200202537B (en)	2003-09-23	Pour-on-formulations.
ZA200201829B (en)	2003-08-27	New phenylpiperazines.
ZA200203762B (en)	2004-01-28	4-pyridinyl-IN-acyl-L-phenylalanines.
ZA991272B (en)	1999-08-18	Novel thiobenzamides.
ZA200108646B (en)	2003-02-26	Electrodes.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
MXPA02001686A (es)	2003-07-14	Hidrociclona.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
MXPA02000261A (es)	2003-08-20	Aminoindanos novedosos.
MXPA01011570A (es)	2003-08-20	Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con peptido h de membrana externa.
MXPA01011670A (es)	2003-10-14	Gen derivado de lawsonia y polipeptidos, peptidos y proteinas sodc relacionadso y sus usos.
MXPA01011669A (es)	2003-09-10	Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con fige y sus usos.
GB0029720D0 (en)	2001-01-17	I.S machine7544232001
ZA200204581B (en)	2003-08-27	Nitro-sulfobenzamides.
ZA992276B (en)	1999-11-24	Oven.
ZA200000214B (en)	2000-10-12	Conveyor.
MXPA01013157A (es)	2003-07-14	Perfil.

Legal Events

Date	Code	Title	Description
2010-11-30	VOID	Decisions declaring the decisions on the grant of the patent lapsed